Submit your email to push it up the queue
Byondis B.V., headquartered in the Netherlands, is a pioneering biopharmaceutical company specialising in the development of innovative antibody-drug conjugates (ADCs) for the treatment of cancer. Founded in 2013, Byondis has rapidly established itself as a key player in the oncology sector, focusing on targeted therapies that enhance the efficacy and safety of cancer treatments. With a strong presence in Europe and expanding operations in the United States, Byondis is committed to advancing its proprietary technologies, including its unique linker and payload systems. The company’s flagship product, a novel ADC, exemplifies its dedication to improving patient outcomes through precision medicine. Byondis has garnered recognition for its scientific advancements and strategic partnerships, positioning itself as a leader in the biopharmaceutical landscape.
How does Byondis B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Byondis B.V.'s score of 23 is lower than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Byondis B.V., headquartered in the Netherlands, currently does not have specific carbon emissions data available, as indicated by the absence of reported emissions figures. The company has not outlined any documented reduction targets or climate pledges, which suggests a lack of formal commitments to measurable climate action at this time. It is important to note that Byondis B.V. is a current subsidiary and may inherit emissions data and climate initiatives from its parent organisation. However, no specific details regarding such cascaded data or initiatives have been provided. In the context of the industry, companies are increasingly expected to set science-based targets and engage in transparent reporting of their carbon footprints. Byondis B.V. may need to consider establishing clear climate commitments and reduction strategies to align with these industry standards and expectations.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Byondis B.V. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.